VANCOUVER, Nov. 11 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. today announced that it will report 2005 third quarter financial results the afternoon of Monday, November 14, 2005. Cardiome will hold a teleconference call and webcast at 4:30pm EST that same day to discuss the results.
The conference call will be hosted by Bob Rieder, President and CEO, Doug Janzen, CFO, Christina Yip, VP, Finance and Administration and Don Graham, Director of Corporate Communication.
To access the conference call, please dial 416-644-3434 or 866-249-2157. There will be a separate dial-in line for analysts on which we will respond to questions at the end of the call. The webcast can be accessed through Cardiome’s website at www.cardiome.com.
Webcast and telephone replays of the conference call will be available approximately two hours after the completion of the call through Monday, November 28, 2005. Please dial 416-640-1917 or 877-289-8525, and enter code No. 21163380 to access the replay.
For Further Information: Don Graham Peter K. Hofman Director of Corporate Communication Director of Investor Relations (604) 676-6963 or (604) 676-6993 or Toll Free: Toll Free: 1-800-330-9928 1-800-330-9928 Email: dgraham@cardiome.com Email: phofman@cardiome.com Forward-Looking Statement Disclaimer
Statements contained in this news release relating to future results, events Email: phofman@cardiome.com and expectation are forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievement of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such statements. Such factors include, among others, those described in the Company’s annual report on Form 40-F. The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Cardiome Pharma Corp.
CONTACT: Don Graham, Director of Corporate Communication, (604) 676-6963or Toll Free: 1-800-330-9928, Email: dgraham@cardiome.com; Peter K. Hofman,Director of Investor Relations, (604) 676-6993 or Toll Free:1-800-330-9928, Email: phofman@cardiome.com
